Collegium Pharmaceutical (COLL) Other Non-Current Assets (2014 - 2026)

Collegium Pharmaceutical's Other Non-Current Assets history runs 13 years deep, the most recent figure standing at $1.1 million for Q1 2026.

• On a quarterly basis, Other Non-Current Assets rose 1.05% year-over-year to $1.1 million in Q1 2026; TTM through Mar 2026 was $1.1 million, a 1.05% increase from a year earlier, with the FY2025 full-year figure at $1.1 million, down 87.38% from the prior year.
• Other Non-Current Assets steadied at $1.1 million in Q1 2026 per COLL's latest filing, from $1.1 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $8.4 million in Q4 2024 and bottomed at $740000.0 in Q3 2023.
• The 5-year median for Other Non-Current Assets is $2.3 million (2025), against an average of $2.3 million.
• Across the five-year window, Other Non-Current Assets surged 699.24% in 2024 and tumbled 87.38% in 2025, its largest moves.
• Year by year, Other Non-Current Assets stood at $2.5 million in 2022, then plunged by 58.89% to $1.0 million in 2023, then jumped by 699.24% to $8.4 million in 2024, then tumbled by 87.38% to $1.1 million in 2025, then increased by 0.19% to $1.1 million in 2026.
• Per Business Quant, the three latest COLL Other Non-Current Assets figures stand at $1.1 million (Q1 2026), $1.1 million (Q4 2025), and $2.3 million (Q3 2025).